The Flowr Corporation has recently shared details of several milestones achieved during the fourth quarter of 2018 that included the company’s first recorded revenues, with nearly 260 kilograms of premium cannabis grown in-house during the period, despite only 20 percent of its facility being operational. Flowr Co-CEO Vinay Tolia noted the significance of the sale as he addressed shareholders during an April 4 conference call.
“The fourth quarter of 2018 marked a major milestone for Flowr, as we launched our medicinal and recreational sales channels after receiving our licenses in August 2018, and sold nearly 406 kilograms of premium cannabis, despite having only 20% of our grow rooms in Kelowna 1 operational during the quarter itself,” Tolia said.
"Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to consistently generate high crop yields of cannabis products. Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to meet pharmaceutical industry production standards for cleanliness without resorting to the taste- and smell-killing gamma irradiation that most other licensed producers use to clean their product," the company explained.
Flowr currently has 10 grow rooms in Kelowna 1 licensed for use, with eight rooms propagated with plants, and expects to have all 20 grow rooms fully constructed by the end of the third quarter of 2019. "Completion of Kelowna 1 should enable the company to begin capitalizing on strategic growth opportunities for medicinal and recreational use, with approximately 10,000 kilograms of capacity for premium cannabis flower on an annualized basis."
For more information:
Flowr
www.flowr.ca